口咽癌经口手术并发症:ACS-NSQIP数据库研究
基于ACS-NSQIP数据库2010至2021年3489例口咽鳞状细胞癌经口手术患者的多机构回顾性队列分析,30天死亡率为0.7%,再入院率8.9%,再手术率5.8%;吸烟和充血性心力衰竭与再入院相关,糖尿病和ASA 3+增加再手术和出血风险。
要点
- 30天死亡率为0.7%,再入院率8.9%,再手术率5.8%。
- 吸烟(OR=1.440)和充血性心力衰竭(OR=3.525)与再入院相关。
- 糖尿病和ASA 3+增加再手术和出血风险。
核心结论
- 本研究再次证明经口手术治疗口咽鳞状细胞癌的安全性,30天再入院率和再手术率低。
- 吸烟、糖尿病、充血性心力衰竭和ASA 3+是并发症的重要术前危险因素。
研究设计与样本
- 多机构回顾性队列分析,使用美国外科医师学会国家手术质量改进计划(ACS-NSQIP)数据库,纳入2010至2021年间3489例接受经口手术的口咽鳞状细胞癌患者。
主要发现
- 平均年龄60.6岁,81.5%为男性。
- 24例死亡,30天死亡率为0.7%。
- 再入院率为8.9%,再手术率为5.8%。
- 吸烟(OR=1.440,95%CI=1.097-1.890)和充血性心力衰竭(OR=3.525,95%CI=1.320-9.414)与再入院相关。
- 糖尿病增加再手术风险(OR=2.679,95%CI=1.110-6.468)和出血风险(OR=3.488,95%CI=1.020-11.926);ASA 3+增加再手术风险(OR=1.701,95%CI=1.233-2.346)和出血风险(OR=2.290,95%CI=1.394-3.764)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Prior studies have highlighted the risk of perioperative mortality due to catastrophic bleeding in patients receiving transoral surgery (TOS) for oropharyngeal squamous cell carcinoma (OPSCC). Although the 30-day mortality and morbidity remain low, understanding the risk factors associated with complications is still required. The goal of this study is to identify risk factors associated with complications after TOS for OPSCC using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database. METHODS: A multi-institutional retrospective cohort analysis of the ACS-NSQIP database identified 3,489 patients undergoing TOS for OPSCC between 2010 and 2021. Preoperative risk factors were collected. The primary outcomes were 30-day readmission, reoperation, hemorrhage, and death. Univariate and multivariate analysis was used to identify preoperative risk factors associated with the primary outcomes. RESULTS: The mean age was 60.6 years, and 81.5% were male. There were 24 deaths (0.7% 30-day mortality rate). The rates of readmission and reoperation were 8.9% and 5.8%, respectively. Smoking (OR = 1.440, 95% CI = 1.097-1.890) and CHF (OR = 3.525, 95% CI = 1.320-9.414) were associated with readmission. Diabetes and ASA 3+ increased the risk of both reoperation (diabetes: OR = 2.679, 95% CI = 1.110-6.468, ASA: OR = 1.701, 95% CI = 1.233-2.346) and hemorrhage (diabetes: OR = 3.488, 95% CI = 1.020-11.926, ASA: OR = 2.290, 95% CI = 1.394-3.764). CONCLUSION: This study redemonstrated the safety of TOS for OPSCC, with low 30-day readmission and reoperation rates. Smoking, diabetes, CHF, and ASA 3+ were important preoperative risk factors for complications. LEVEL OF EVIDENCE: 3 Laryngoscope, 135:2385-2391, 2025.
引用
- Wong S, Tang L, Kwon D, et al. Complications After Transoral Surgery for Oropharyngeal Cancer: An ACS-NSQIP Database Study. Laryngoscope. 2025. PMID: 39835718. doi:10.1002/lary.32014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。